B. Braun receives FDA approval for new pharmaceutical manufacturing plant in Daytona Beach

B. Braun Medical Inc. received FDA approval for its new pharmaceutical manufacturing plant in Daytona Beach, Florida. The site will produce 0.9% Sodium Chloride for Injection in IV bags, with product deliveries expected to begin in late February 2022.

“B. Braun Medical Inc. ... announced that the company has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical manufacturing plant in Daytona Beach, FL.”prnewswire.com

• 1 source
• prnewswire.comB. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing SiteB. Braun Medical Inc.Jan 28, 2022

Summarized from public sources; check the original articles before acting on it.